552 related articles for article (PubMed ID: 11110019)
1. Selective serotonin reuptake inhibitors in the treatment of paediatric anxiety disorders: a review.
Murphy TK; Bengtson MA; Tan JY; Carbonell E; Levin GM
Int Clin Psychopharmacol; 2000 Aug; 15 Suppl 2():S47-63. PubMed ID: 11110019
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy of selective serotonin reuptake inhibitor treatment in children and adolescents].
Bailly D
Presse Med; 2006 Sep; 35(9 Pt 2):1293-302. PubMed ID: 16969324
[TBL] [Abstract][Full Text] [Related]
3. Anxiety disorders: a review of tricyclic antidepressants and selective serotonin reuptake inhibitors.
Zohar J; Westenberg HG
Acta Psychiatr Scand Suppl; 2000; 403():39-49. PubMed ID: 11019934
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
Pelissolo A
Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
[TBL] [Abstract][Full Text] [Related]
5. Fluvoxamine. An updated review of its use in the management of adults with anxiety disorders.
Figgitt DP; McClellan KJ
Drugs; 2000 Oct; 60(4):925-54. PubMed ID: 11085201
[TBL] [Abstract][Full Text] [Related]
6. Spotlight on paroxetine in psychiatric disorders in adults.
Wagstaff AJ; Cheer SM; Matheson AJ; Ormrod D; Goa KL
CNS Drugs; 2002; 16(6):425-34. PubMed ID: 12027788
[TBL] [Abstract][Full Text] [Related]
7. Selective serotonin reuptake inhibitor use in the treatment of the pediatric non-obsessive-compulsive disorder anxiety disorders.
Seidel L; Walkup JT
J Child Adolesc Psychopharmacol; 2006; 16(1-2):171-9. PubMed ID: 16553537
[TBL] [Abstract][Full Text] [Related]
8. Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability.
Kolevzon A; Mathewson KA; Hollander E
J Clin Psychiatry; 2006 Mar; 67(3):407-14. PubMed ID: 16649827
[TBL] [Abstract][Full Text] [Related]
9. [Neurobiology and pharmacotherapy of social phobia].
Aouizerate B; Martin-Guehl C; Tignol J
Encephale; 2004; 30(4):301-13. PubMed ID: 15538306
[TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapy for anxiety and comorbid alcohol use disorders.
Ipser JC; Wilson D; Akindipe TO; Sager C; Stein DJ
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD007505. PubMed ID: 25601826
[TBL] [Abstract][Full Text] [Related]
11. [Selective serotonin reuptake inhibitor(SSRI)].
Motohashi N
Nihon Rinsho; 2001 Aug; 59(8):1519-22. PubMed ID: 11519151
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of selective serotonin reuptake inhibitors in adult social anxiety disorder: a meta-analysis of double-blind, placebo-controlled trials.
Hedges DW; Brown BL; Shwalb DA; Godfrey K; Larcher AM
J Psychopharmacol; 2007 Jan; 21(1):102-11. PubMed ID: 16714326
[TBL] [Abstract][Full Text] [Related]
13. [Treatment-resistant anxiety disorders: A literature review of drug therapy strategies].
Ammar G; Naja WJ; Pelissolo A
Encephale; 2015 Jun; 41(3):260-5. PubMed ID: 25439852
[TBL] [Abstract][Full Text] [Related]
14. Biological dissection of anxiety disorders: the clinical role of selective serotonin reuptake inhibitors with particular reference to fluvoxamine.
den Boer JA; Westenberg HG; De Leeuw AS; van Vliet IM
Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():47-52. PubMed ID: 7622824
[TBL] [Abstract][Full Text] [Related]
15. Venlafaxine in the treatment of anxiety disorders.
Katzman M
Expert Rev Neurother; 2004 May; 4(3):371-81. PubMed ID: 15853535
[TBL] [Abstract][Full Text] [Related]
16. [Documented effects of SSRI preparations in anxiety].
Allgulander C
Lakartidningen; 1998 May; 95(21):2464-7. PubMed ID: 9640919
[TBL] [Abstract][Full Text] [Related]
17. Selective serotonin reuptake inhibitors in children and adolescents.
Diler RS; Avci A
Swiss Med Wkly; 2002 Aug; 132(33-34):470-7. PubMed ID: 12458447
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic treatment of anxiety disorders in children and adolescents.
Velosa JF; Riddle MA
Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):119-33. PubMed ID: 10674193
[TBL] [Abstract][Full Text] [Related]
19. Amotivational syndrome associated with selective serotonin reuptake inhibitors in children and adolescents.
Garland EJ; Baerg EA
J Child Adolesc Psychopharmacol; 2001; 11(2):181-6. PubMed ID: 11436958
[TBL] [Abstract][Full Text] [Related]
20. Where are we going with SSRIs?
Isaac M
Eur Neuropsychopharmacol; 1999 Jul; 9 Suppl 3():S101-6. PubMed ID: 10523065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
